159 related articles for article (PubMed ID: 23674865)
21. Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins.
Solfrizzo M; Gambacorta L; Lattanzio VM; Powers S; Visconti A
Anal Bioanal Chem; 2011 Nov; 401(9):2831-41. PubMed ID: 21892639
[TBL] [Abstract][Full Text] [Related]
22. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
23. Utilising an LC-MS/MS-based multi-biomarker approach to assess mycotoxin exposure in the Bangkok metropolitan area and surrounding provinces.
Warth B; Petchkongkaew A; Sulyok M; Krska R
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(12):2040-6. PubMed ID: 25268629
[TBL] [Abstract][Full Text] [Related]
24. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
25. Aflatoxins as a cause of hepatocellular carcinoma.
Kew MC
J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma.
Ferreira RG; Cardoso MV; de Souza Furtado KM; Espíndola KMM; Amorim RP; Monteiro MC
Transl Res; 2019 Feb; 204():51-71. PubMed ID: 30304666
[TBL] [Abstract][Full Text] [Related]
27. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
29. The public health significance of mycotoxins.
Rutledge AE
Ann Nutr Aliment; 1977; 31(4-6):1009-30. PubMed ID: 207207
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous determination of six mycotoxins in peanut by high-performance liquid chromatography with a fluorescence detector.
Chen F; Luan C; Wang L; Wang S; Shao L
J Sci Food Agric; 2017 Apr; 97(6):1805-1810. PubMed ID: 27476832
[TBL] [Abstract][Full Text] [Related]
31. Challenging Role of Dietary Aflatoxin B1 Exposure and Hepatitis B Infection on Risk of Hepatocellular Carcinoma.
Kucukcakan B; Hayrulai-Musliu Z
Open Access Maced J Med Sci; 2015 Jun; 3(2):363-9. PubMed ID: 27275251
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma and impact of aflatoxin difuranocoumarin derivative system – A case report.
Ilić M; Putnik SS; Prvulović-Bunović N; Vojinović-Miloradov M; Mihajlović I; Turk-Sekulić M; Radonić J
Srp Arh Celok Lek; 2016; 144(11-12):661-3. PubMed ID: 29659235
[TBL] [Abstract][Full Text] [Related]
33. Aflatoxins as risk factors for hepatocellular carcinoma in humans.
Wogan GN
Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989
[TBL] [Abstract][Full Text] [Related]
34. Fumonisin B1 and risk of hepatocellular carcinoma in two Chinese cohorts.
Persson EC; Sewram V; Evans AA; London WT; Volkwyn Y; Shen YJ; Van Zyl JA; Chen G; Lin W; Shephard GS; Taylor PR; Fan JH; Dawsey SM; Qiao YL; McGlynn KA; Abnet CC
Food Chem Toxicol; 2012 Mar; 50(3-4):679-83. PubMed ID: 22142693
[TBL] [Abstract][Full Text] [Related]
35. Dietary exposure to aflatoxin B
Huong BTM; Tuyen LD; Tuan DH; Brimer L; Dalsgaard A
Food Chem Toxicol; 2016 Dec; 98(Pt B):127-133. PubMed ID: 27746326
[TBL] [Abstract][Full Text] [Related]
36. Mycotoxins in herbal teas marketed in Latvia and dietary exposure assessment.
Reinholds I; Bogdanova E; Pugajeva I; Bartkevics V
Food Addit Contam Part B Surveill; 2019 Sep; 12(3):199-208. PubMed ID: 30961455
[TBL] [Abstract][Full Text] [Related]
37. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
[TBL] [Abstract][Full Text] [Related]
38. Liver cancer and mycotoxins.
Linsell A
IARC Sci Publ; 1984; (63):161-5. PubMed ID: 6100267
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurements.
Palli D; Miraglia M; Saieva C; Masala G; Cava E; Colatosti M; Corsi AM; Russo A; Brera C
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):265-9. PubMed ID: 10090305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
